Calcimimetic compounds: A direct approach to controlling plasma levels of parathyroid hormone in hyperparathyroidism

Trends in Endocrinology and Metabolism

Volumn 10, Issue 2, 1999, Pages 66-71

  Nemeth, Edward F ^a   Fox, John ^a  

^a NPS Pharmaceutical Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; AMINOGLYCOSIDE; CALCIUM; CALCIUM CHANNEL STIMULATING AGENT; CATION; GADOLINIUM; GENTAMICIN; KANAMYCIN B; LIGAND; MAGNESIUM; NEOMYCIN; PARATHYROID HORMONE; PHENYLALKYLAMINE; POLYAMINE; POLYARGININE; POLYLYSINE; PROTAMINE; SPERMIDINE; SPERMINE; STREPTOMYCIN;

CALCIUM BLOOD LEVEL; CELL HYPERPLASIA; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; DRUG EFFICACY; DRUG INHIBITION; DRUG RECEPTOR BINDING; DRUG SAFETY; HEMODIALYSIS PATIENT; HORMONE RELEASE; HYPERPARATHYROIDISM; NONHUMAN; ORAL DRUG ADMINISTRATION; PARATHYROID CELL; PARATHYROID HORMONE BLOOD LEVEL; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; RAT; REVIEW; SECONDARY HYPERPARATHYROIDISM; STEREOCHEMISTRY;

EID: 0033029793     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-2760(98)00119-2     Document Type: Review

References (35)

1. Arnold, A. (1994) Molecular basis of primary hyperparathyroidism. In The Parathyroids (Bilezikian, J.P., Levine, M.A. and Marcus, R., eds), pp 407-421, Raven Press.
2. Drüeke T.B. The pathogenesis of parathyroid gland hyperplasia in chronic renal failure. Kidney Int. 48:1995;259-272.
3. Bilezikian, J.P. (1994) Guidelines for the medical or surgical management of primary hyperparathyroidism. In The Parathyroids (Bilezikian, J.P., Levine, M.A. and Marcus, R., eds), pp 567-574, Raven Press.
4. Garrett J.E.et al. Calcitonin-secreting cells of the thyroid express an extracellular calcium receptor gene. Endocrinology. 136:1995;5202-5211.
5. Brown E.M., Hebert S.C. Calcium-receptor-regulated parathyroid and renal function. Bone. 20:1997;303-309.
6. 2+-sensing receptor from bovine parathyroid. Nature. 366:1993;575-580.
7. Brown E.M. Mutations in the calcium-sensing receptor and their clinical implications. Horm. Res. 48:1997;199-208.
8. Steffey, M.E., Fox, J., VanWagenen, B.C., DelMar, E.G., Balandrin, M.F. and Nemeth, E.F. (1993) Calcimimetics: structurally and mechanistically novel compounds that inhibit hormone secretion from parathyroid cells. J. Bone Miner. Res. 8, S175 (Abstr.).
9. Hammerland, L.G., Brown, E.M., Hebert, S.C. and Nemeth, E.F. (1993) Mechanism of action of the calcimimetic compounds NPS R-467 and NPS R-568 in Xenopus oocytes expressing a bovine parathyroid cell calcium receptor. J. Bone Miner. Res. 8, S133 (Abstr.).
10. Nemeth, E.F. (1996) Calcium receptors as novel drug targets. In Principles of Bone Biology, pp 1019-1035, Academic Press.
11. Nemeth E.F.et al. Calcimimetics with potent and selective activity on the parathyroid calcium receptor. Proc. Natl. Acad. Sci. U. S. A. 95:1998;4040-4045.
12. 2+ receptor expressed in Xenopus laevis oocytes by NPS 467 and NPS 568. Mol. Pharmacol. 53:1998;1083-1088.
13. 2+ receptors. Mol. Pharmacol. (in press).
14. Ward D.T., Brown E.M., Harris H.W. Disulfide bonds in the extracellular calcium-polyvalent cation-sensing receptor correlate with dimer formation and its response to divalent cations in vitro. J. Biol. Chem. 273:1998;14476-14483.
15. Silverberg S.J.et al. Short-term inhibition of parathyroid hormone secretion by a calcium-receptor agonist in patients with primary hyperparathyroidism. New Engl. J. Med. 337:1997;1506-1510.
16. Shane, E. (1994) Parathyroid carcinoma. In The Parathyroids (Bilezikian, J.P., Levine, M.A. and Marcus, R., eds), pp 575-581, Raven Press.
17. Collins M.T., Skarulis M.C., Bilezikian J.P., Silverburg S.J., Spiegel A.M., Marx S.J. Treatment of hypercalcemia secondary to parathyroid carcinoma with a novel calcimimetic agent. J. Clin. Endocrinol. Metab. 83:1998;1083-1088.
18. Coburn, J.W. and Salusky, I.B. (1994) Hyperparathyroidism in renal failure. In The Parathyroids (Bilezikian, J.P., Levine, M.A. and Marcus, R., eds), pp 721-745, Raven Press.
19. Quarles L.D.et al. Prospective trial of pulse oral versus intravenous calcitriol treatment of hyperparathyroidism in ESRD. Kidney Int. 45:1994;1710-1721.
20. Herrmann P.et al. Comparison of intermittent and continuous oral administration of calcitriol in dialysis patients. A randomized prospective trial. Nephron. 67:1994;48-53.
21. Antonsen J.E., Sherrard D.J., Andress D.L. A calcimimetic agent acutely suppresses parathyroid hormone levels in patients with chronic renal failure. Kidney Int. 53:1998;223-227.
22. Sherrard D.J. Calcimimetics in action. Kidney Int. 53:1997;510-511.
23. Fajtova V.T., Sayegh M.H., Hickey N., Aliabadi P., Lazarus J.M., LeBoff M.S. Intact parathyroid hormone levels in renal insufficiency. Calcif. Tissue Int. 57:1995;329-335.
24. Wada M., Ishii H., Furuya Y., Fox J., Nemeth E.F., Nagano N. NPS R-568 halts or reverses osteitis fibrosa in uremic rats. Kidney Int. 53:1998;448-453.
25. Wada M.et al. The calcimimetic compound NPS R-568 suppresses parathyroid cell proliferation in rats with renal insufficiency: control of parathyroid cell growth via a calcium receptor. J. Clin. Invest. 100:1997;2977-2983.
26. Garrett, J.E., Steffey, M.E. and Nemeth, E.F. (1995) The calcium receptor agonist NPS R-568 suppresses PTH mRNA levels in cultured bovine parathyroid cells. J. Bone Miner. Res. 10, S387 (Abstr.).
27. Slatopolsky, E. and Brown, A.J. (1998) Parathyroid hormone in health and chronic renal disease. In Renal Osteodystrophy (Bushinsky, D.A., ed.), pp 129-160, Lippincott-Raven.
28. Dempster D.W., Cosman F., Parisien M., Shen V., Lindsay R. Anabolic actions of PTH in bone. Endocr. Rev. 14:1993;690-709.
29. Cosman F., Lindsay R. Is parathyroid hormone a therapeutic option for osteoporosis? A review of the clinical evidence. Calcif. Tissue Int. 62:1998;475-480.
30. Gogusev J.et al. Depressed expression of calcium receptor in parathyroid gland tissue of patients with hyperparathyroidism. Kidney Int. 51:1997;328-336.
31. 2+-sensing receptor in primary and uremic secondary hyperparathyroidism. J. Clin. Endocrinol. Metab. 81:1996;1598-1606.
32. Nemeth, E.F. et al. (1998) Stimulation of parathyroid hormone secretion by a small molecule antagonist of the calcium receptor. Bone 23, S156 (Abstr.).
33. 2+ receptor stimulates PTH secretion and bone turnover in osteopenic ovariectomized rats. Bone 23, S163 (Abstr.).
34. Lavigne, J.R. et al. Stimulation of calcitonin secretion by calcium receptor activators: evaluation using a new, highly sensitive, homologous immunoradiometric assay for rat calcitonin. Endocrine (in press).
35. Nemeth E.F., Bennett S.A. Tricking the parathyroid gland with novel calcimimetic agents. Nephrol. Dial. Transplant. 13:1998;1923-1925.